Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States

Archives of Internal Medicine

Volumn 157, Issue 22, 1997, Pages 2601-2605

  Mahoney, Francis J ^a   Stewart, Kimberly ^a,b   Hu, Hanxian ^a   Coleman, Patrick ^a   Alter, Miriam J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ACTIVE IMMUNIZATION; ARTICLE; FEMALE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HEPATITIS B; HUMAN; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; VIRUS TRANSMISSION;

EID: 0030691203     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.22.2601     Document Type: Article

References (36)

1. Gibas A, Blenett DR, Scnoenteld DA, et al. Prevalence and incidence of viral hepatitis in health workers in the prehepatitis B vaccination era. Am J Epidemiol. 1992;136:603-610.
2. Dienstag JL, Ryan DM. Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization? Am J Epidemiol. 1982;115:26-39.
3. Hadler SC, Doto IL, Maynard JE, et al. Occupational risk of hepatitis B infection in hospital workers. Infect Control. 1985;6:24-31.
4. Osterholm MT, Garayalde SM. Clinical viral hepatitis B among Minnesota hospital personnel: results of a ten-year statewide survey. JAMA. 1985;254:3207-3212.
5. West DJ. The risk of hepatitis B infection among health professionals in the United States: a review. Am J Med Sci. 1984;287:26-33.
6. Hick CG, Hargis CO, Harris JR. Prevalence survey for hepatitis B in high-risk university hospital employees. Am J Infect Control. 1985;13:1-6.
7. Centers for Disease Control. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health care workers and public safety workers. MMWR Morb Mortal Wkly Rep. 1989;38:S6.
8. Mast EE, Alter MJ. Prevention of hepatitis B virus infection among health care workers. In: Hepatitis B Vaccines in Clinical Practice. New York, NY: Marcel Dekker Inc; 1993:295-307.
9. Centers for Disease Control. Inactivated hepatitis B virus vaccine. MMWR Morb Mortal Wkly Rep. 1982;31:34.
10. Crossley KB, Gerding DN, Petzel RA. Acceptance of hepatitis B vaccine by hospital personnel. Infect Control. 1985;6:147-149.
11. Bodenheimer HC, Fulton JP, Kramer PD. Acceptance of hepatitis B vaccination among hospital workers. Am J Public Health. 1986;76:253-255.
12. Lewy R. Immunizations among hospital personnel. J Occup Med. 1987;29:433-436.
13. Harward MP, Kaiser DL, Fedson DS. Acceptance of hepatitis B vaccine by medical and surgical residents. J Gen Intern Med. 1988;3:150-155.
14. Hashimoto F, Hunt WC, Brusuelas P. Physician acceptance of the hepatitis B vaccine at a university medical center. Am J Public Health. 1988;78:973-974.
15. Scapa E, Karpuch J, Waron M, Eschar J. Attitude of hospital personnel toward hepatitis B vaccination. Am J Gastroenterol. 1989;84:400-402.
16. Spence MR, Dash GP. Hepatitis B: perceptions, knowledge and vaccine acceptance among registered nurses in high-risk occupations in a university hospital. Infect Control Hosp Epidemiol. 1990;11:129-133.
17. Murata PJ, Young LC. Physicians' attitudes and behaviors regarding hepatitis B immunization. J Fam Pract. 1993;36:163-168.
18. US Department of Labor, Occupational Safety and Health Administration. Occupational exposure to blood-borne pathogens: final rule. Federal Register. December 6, 1991;56:64004-64182.
19. Agerton TB, Mahoney FJ, Polish LB, Shapiro CM. Impact of the blood-borne pathogens standard on vaccination of healthcare workers with hepatitis B vaccine. Infect Control Hosp Epidemiol. 1995;16:287-291.
20. Stevens CE, Toy PT, Taylor PE, Lee T, Yip HY. Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long term protection. Pediatrics. 1992;90(suppl):170-173.
21. Wainwright RB, Buklow LR, Parkinson AJ, Zanis C, McMahon BJ. Protection provided by hepatitis B vaccine in a Yupik Eskimo population: results of a 10-year study. J Infect Dis. 1997;175:674-677.
22. Hadler SC, Judson FN, O'Malley PM, et al. Studies of hepatitis B vaccine in homosexual men. In: Coursaget P, Tong MJ, eds. Progress in Hepatitis B Immunization. Paris, France: John Libby Eurotest; 1990:165-175.
23. Goh KT, Oon CJ, Heng BH, Lim GK. Long-term immunogenicity and efficacy of a reduced dose of plasma-based hepatitis B vaccine in young adults. Bull World Health Organ. 1995,73:523-527.
24. Taylor PE, Stevens CE. Persistence of antibody to hepatitis B surface antigen after vaccination in healthy adults. In: Zuckermann AJ, ed. Viral Hepatitis and Liver Disease. New York, NY: Alan R Liss Inc; 1988:995-997.
25. Courouce AM, Loplanche A, Benhamou E, Jungers P. Long-term efficacy of hepatitis B vaccination in healthy adults. In: Zuckermann AJ, ed. Viral Hepatitis and Liver Disease. New York, NY: Alan R Liss Inc; 1988:1002-1005.
26. Gibas A, Watkins E, Hinkle C, Dienstag JL. Long-term persistence of protective antibody after hepatitis B vaccination of healthy adults, In: Zuckermann AJ, ed. Viral Hepatitis and Liver Disease. New York, NY: Alan R Liss Inc; 1988:998-1001.
27. Davidson M, Krugman S. Recombinant yeast hepatitis B vaccine compared with plasma-derived vaccine: immunogenicity and effect of a booster dose. J Infect. 1986;13(suppl):31-38.
28. Jilg W, Schmidt M, Deinhardt F, Persistence of specific antibodies after hepatitis B vaccination. J Hepatol. 1988;6:201-207.
29. Centers for Disease Control and Prevention. Hepatitis Surveillance Report No. 56. Atlanta, Ga: Centers for Disease Control and Prevention; 1996:9-14.
30. McMahon BJ, Alward WL, Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis. 1985;151:599-603.
31. Crosnier J, Jungers P, Courouce AM, et al. Randomized placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units, I: medical staff. Lancet. 1981;1:455-459.
32. Milne A, Waldon J. Recombinant DNA hepatitis B vaccination in teenagers: effect of a booster dose at 5 1/2 years. J Infect Dis. 1992;166:942.
33. Milne A, Krugman S, Waldon JA, et al. Hepatitis B vaccination in children: five year booster study. N Z Med J. 1992;26:336-338.
34. Horowitz MM, Ershler WB, McKinney WP, Battiola RJ. Duration of immunity after hepatitis B vaccination: efficacy of low-dose booster vaccine. Ann Intern Med. 1988;108:185-189.
35. Chan CY, Lee SD, Tsai YT, Lo KJ. Booster response to recombinant yeast-derived hepatitis B vaccine in vaccinees whose anti-HBs response were elicited by a plasma-derived vaccine. Vaccine. 1991;9:765-767.
36. Moyes CD, Milne A, Waldon J. Very low dose hepatitis B vaccination in the newborn: anamnestic response to a booster dose at four years. J Med Virol. 1990;30:216-218.